Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02233673 · ClinicalTrials.gov registry record · NA

Incentives Targeting Gestational Weight Gain in Overweight/Obese Low Income Women

A NA study of Obesity and Overweight, sponsored by University of Vermont.

Completed
Registry status
NA
Development phase
136
Enrollment target
1
Study location

NCT02233673: Completed NA study of Obesity and Overweight, sponsored by University of Vermont.

NCT02233673 is a NA study of Obesity and Overweight that has completed, run by University of Vermont. The registered enrollment target is 136 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02233673, a NA study of Obesity and Overweight, has completed, sponsored by University of Vermont.

COMPLETED
Registry status
NA
Development phase
136 participants
Enrollment target
1
Study location

Study Summary

Excessive weight gain during pregnancy, particularly in overweight and obese women, predisposes to adverse perinatal outcomes and has long term effects on maternal and neonatal health. With an inverse relationship between socioeconomic status and obesity, significant health disparities exist between obese and normal weight women. The Institute of Medicine (IOM) recently revised its gestational weight gain recommendations, targeted to pregravid body mass index (BMI), to minimize pregnancy complications. However, these recommendations are based on cross sectional observational studies and neither the ideal method to achieve weight gain goals nor whether perinatal outcome is optimized with active management of weight gain is known. The investigators propose to investigate a behavioral incentive-based intervention to improve compliance with IOM weight gain recommendations during pregnancy in low-income overweight and obese women. The investigators will evaluate if 1) gestational weight gain can be reliably targeted to the IOM recommendations and 2) active weight gain management during pregnancy improves perinatal outcomes. Two study groups will be compared in a prospective randomized trial; 1) those receiving standard obstetrical care and 2) those receiving behavioral weight management counseling plus financial incentives for achieving weight gain goals. The main outcome measure will be the percentage of women gaining within the IOM recommendations based on prepregnancy BMI. Secondary outcomes evaluated will include fetal growth and body composition changes, birth weight and the rate of cesarean delivery. The investigators hypothesize that 1) the behavioral intervention with incentives will result in greater compliance to IOM guidelines for gestational weight gain than standard care and 2) targeting weight gain to the IOM guidelines will lead to a reduction in the rates of fetal macrosomia and cesarean delivery. Finally, cost effectiveness of treatment conditions will b

Primary Outcome

Total gestational weight gain at time of last prenatal visit. For participants in the intervention arm, gestational weight gain at 2 week intervals will also be assessed.

Interventions

  • BEHAVIORAL Financial incentives

Study Locations (1)

Vermont

  • University of Vermont - Burlington

Trial Details

FieldValue
Enrollment Target 136 participants
Start Date 2014-03
Est. Completion 2017-08-28
Phase NA
University of Vermont

162 total trials

What the finished NCT02233673 record still lists

NCT02233673 is an interventional study that assigns participants to a tested intervention. The registered 136 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (83% lower).

The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Financial incentives is the first listed.

NCT02233673 reports a single indexed study location in Vermont.

Frequently Asked Questions

What is clinical trial NCT02233673 about?

NCT02233673 is a clinical study titled "Incentives Targeting Gestational Weight Gain in Overweight/Obese Low Income Women". Excessive weight gain during pregnancy, particularly in overweight and obese women, predisposes to adverse perinatal outcomes and has long term effects on maternal and neonatal health. With an inverse relationship between socioeconomic status and obesity, significant health disparities exist between...

What is the current status of trial NCT02233673?

This trial is currently completed. It is a NA study. The enrollment target is 136 participants. The study started on 2014-03. Estimated completion is 2017-08-28.

What conditions does trial NCT02233673 study?

This clinical trial studies the following conditions: Obesity, Overweight, Pregnancy.

What interventions are being tested in trial NCT02233673?

The interventions under investigation include: Financial incentives (BEHAVIORAL).

Who is sponsoring clinical trial NCT02233673?

This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02233673 being conducted?

This trial has 1 study location across Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02233673's enrollment target sits among peer trials

136 407th of 1053 higher than 641 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01555892 · 136 participants · Phase 1

    Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE

  • NCT03216525 · 136 participants · Phase 3

    Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol

  • NCT04476901 · 136 participants · Phase 2

    Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy

  • NCT04603898 · 136 participants · NA

    Oxalate Formation From Ascorbic Acid

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02233673, the US trial registry maintained by the National Library of Medicine. NCT02233673 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.